MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Tremeau.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Tremeau.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Tremeau.com most likely does not offer any adult content.
Popular pages
-
Tremeau Receives May Proceed Notification From FDA For Phase III Program in Acute Migraine For TRM
This is the second IND opened for a clinical program developing Tremeau’s lead asset.
-
Tremeau Pharmaceuticals ACR Convergence 2022 Presentations Highlight Potential Path Forward for
Tremeau is presenting two abstracts at ACR Convergence 2022.
-
Pipeline
Leading the way for those left behind in pain
-
Strategy
Paving a path toward opioid-free pain relief for the patients who need it most.
-
Approach
Tremeau was founded with the goal of developing and delivering non-opioid pain therapies for people with rare diseases and other select conditions
-
FDA Grants Orphan Drug Designation for TRM-201 (rofecoxib) for the Treatment of Hemophilic
Tremeau announced today that the U.S. Food and Drug Administration (FDA) has granted an orphan drug designation, on a first cycle review, for TRM-201...